Jundishapur Journal of Chronic Disease Care

Published by: Kowsar

Prevalence of Co-Infections of Hepatitis B and C Among Drug Abuse: Prisoners and Its Association With High Risk Behavior

Behrooz Ataei 1 , Payman Adibi 2 , Zary Nokhodian 1 , Marjan Meshkati 3 and Zahra Boroumandfar 4 , *
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Department of Infectious Diseases, Medical School, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Functional Gastroenterology Research Center, Department of Gastroenterology, Medical School, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Health Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
4 Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Jundishapur Journal of Chronic Disease Care: January 01, 2015, 4 (1); e26620
  • Published Online: January 20, 2015
  • Article Type: Research Article
  • Received: August 11, 2014
  • Revised: October 28, 2014
  • Accepted: December 29, 2014
  • DOI: 10.5812/jjcdc.26620

To Cite: Ataei B, Adibi P, Nokhodian Z, Meshkati M, Boroumandfar Z. Prevalence of Co-Infections of Hepatitis B and C Among Drug Abuse: Prisoners and Its Association With High Risk Behavior, Jundishapur J Chronic Dis Care. 2015 ; 4(1):e26620. doi: 10.5812/jjcdc.26620.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Footnote
References
  • 1. Azarkar Z, SharifzadAeh G, Miraki MA. HBV, HCV and HIV prevalence among-south Khorasan prisoners. J Birjand Univ Med Sci. 2007; 14(2): 9-15
  • 2. Rowhani RA, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy. 2004; 15(2): 151-5
  • 3. Communicable disease office. 2010;
  • 4. Urgancı N, Gulec S, Dogan S, Nuhoglu A. Interferon and ribavirin treatment results of patients with HBV–HCV co-infection cured of childhood malignancies. Int J Infect Dis. 2006; 10(6): 453-7
  • 5. Liaw Y. Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. J gastroenterology. 2002; 37(13): 65-8
  • 6. Roshandel G, Semnani S, Abdolahi N, Besharat S, Kashtkar A, Joshaghani H, et al. The prevalence of Co-infection with HCV and HDV in HBV infected patients in Golestan province of Iran. J Gorgan Univ Med Sci. 2008; 9(4): 61-5
  • 7. Adoga M, Banwat E, Forbi J, Nimzing L, Pam C, Gyar S, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria. J Infection Develop Countries. 2009; 3(7): 539-47
  • 8. La Torre G, Miele L, Chiaradia G, Mannocci A, Reali M, Gasbarrini G, et al. Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. BMC Infect Dis. 2007; 7: 100[DOI][PubMed]
  • 9. Mohtasham A, Rezvani M, Jafari Shakib R, Jafari Shakib A. Prevalence of HCV and high-risk behaviors in drug addiction inmates in Rasht, Iran. J Payesh. 2009; 8: 335-41
  • 10. Shamsaddini S, Nasiri Kashani M, Sharifi I, Kajeh K, Pourlashkari M. Prevalence of infectious skin diseases in the central prison of Kerman. Iranian J Dermatol. 2000; 4(13): 19-25
  • 11. Ataei B, Khorvash F, Azadeh S, Nokhodian Z, Kassaian N, Babak A. The prevalence of high risk behaviors among women prisoners in isfahan, iran. J Isfahan Med Sch. 2011; 29(150): 1070-7
  • 12. Miller RW, Forcehimes A, O'Leary M, LaNoue M. Spiritual direction in addiction treatment: Two clinical trials. J Subs Abuse Treat. 2008; 35(4): 434-42
  • 13. Nejat S, Feyzzadeh A, Asghari S, Keshtkar A, Heshmat R. HIV risk factors in Iran; systematic review, meta-analysis and generalized impact fraction approaches. J Payesh. 2007; 6(1): 45-54
  • 14. Diagnostic bioprobes.
  • 15. Sabbatani S, Giuliani R, Fulgaro C, Paolillo P, Baldi E, Chiodo F. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests]. Epidemiologia e prevenzione. 2003; 28(3): 163-8
  • 16. Macalino G, Vlahov D, Sanford C, Patel S, Sabin K, Salas C, et al. Prevalence and Incidence of HIV, Hepatitis B Virus, and Hepatitis C Virus Infections Among Males in Rhode Island Prisons. American J Public Health. 2004; 94(7): 1218-23[DOI]
  • 17. De La Hoya PS, Marco A, García-Guerrero J, Rivera A. Hepatitis C and B prevalence in Spanish prisons. Eur j Clinic Microbiol Infectious Dis. 2011; 30(7): 857-62
  • 18. Sattar SA, Tetro J, Springthorpe VS, Giulivi A. Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control. 2001; 29(3): 187-97
  • 19. Savabi O, Hasankhani A, Mohamadikhah Z. The Attitude and Practice of Dentists in Relation with HIV and HBV Infected Patients in Isfahan Province. Iran J Med Educ. 2011; 10(5): 868-85
  • 20. Rad M, Kakoei S, Fatahi T. . Evaluation of knowledge, attitude and practice of dental patients of smoking effects on oral health. J Isfahan Dent Sch. 2008; 3(3): 118-25
  • 21. Tortu S, McMahon JM, Hamid R, Neaigus A. Women's drug injection practices in East Harlem: An event analysis in a high-risk community. AIDS Behav. 2003; 7(3): 317-28
  • 22. Imani R, Karymi A, Kasaeeian N. The relevance of related-risk behaviors and seroprevalence of HBV, HCV and HIV infection in intravenous drug users from Shahrekord, Iran, 2004. Shahrekord Univ Med Sci J. 2006; 8(1): 58-62
  • 23. Stark K, Herrmann U, Ehrhardt S, Bienzle U. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Epidemiol Infect J. 2006; 134(4): 814-9
  • 24. Ataei B, Salehi A, Javadi AK, Horvash F, Mortazavi A, Kasaeian N, et al. The Frequency of High-risk Behaviors in Intravenous Drug Abusers Referred to Addiction Prohibition Centers in Isfahan, 2010. J Isfahan Med Sch. 2011; 28(114)
  • 25. Cocozella DR, Albuquerque MM, Borzi S, Barrio M, Dascenzo V, Santecchia JC, et al. [Prevalence of hepatic involvement, alcoholism, hepatis B, C and HIV in patients with background history of drug use]. Acta Gastroent Latinoameric J. 2002; 33(4): 177-81
  • 26. Etard JF, Colbachini P, Dromigny JA, Perrier-Gros-Claude JD. Hepatitis C antibodies among blood donors, Senegal, 2001. Emerg Infect Dis. 2003; 9(11): 1492-3
  • 27. Azizi A, Amirian F, Amirian M. Prevalence and Associated Factors of Hepatitis C in Self-introduced Substance Abusers. Hayat. 2011; 17(1): 55-61
  • 28. Mojtahedzadeh V, Razani N, Malekinejad M, Vazirian M, Shoaee S, Zafarghandi MB, et al. Injection drug use in rural Iran: Integrating HIV prevention into Iran’s rural primary health care system. AIDS Behav. 2008; 12(1): 7-12
  • 29. Des Jarlais DC, Semaan S. HIV prevention for injecting drug users: the first 25 years and counting. Psychosom Med. 2008; 70(5): 606-11
  • 30. Mohammad K, Asgari F, Fotouhi A, Yousefi A. Prevalence of Hepatitis B Virus (HBV) infection among Iranian prisoners during 2001-2005. J Payesh. 2008; 7(3): 279-86
  • 31. Fadaei Nobari R, Meshkati M, Ataei B, Heidari K, Kassaian N, Nokhodian Z, et al. Positive Hepatitis C Virus Antibody in Cases with History of Intravenous Drug Abuse via Community Announcement: A Useful Experience. J Isfahan Med Sch. 2011; 28: 1546-52
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments